How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19
暂无分享,去创建一个
M. Rudenko | M. Maurer | B. Wedi | P. Kolkhir | L. Ensina | C. Grattan | P. Criado | M. Gotua | M. Muñoz | E. Kocatürk | Daniel Elieh-Ali-Komi | J. Peter | P. Can
[1] M. Maurer,et al. Features of Chronic Spontaneous Urticaria Induced by COVID-19 , 2023, International Archives of Allergy and Immunology.
[2] R. Hui,et al. Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines , 2023, Journal of autoimmunity.
[3] S. Frischbutter,et al. Chronic urticaria and the pathogenic role of mast cells. , 2023, Allergology international : official journal of the Japanese Society of Allergology.
[4] M. Maurer,et al. Virus‐infected mast cells activate virus‐specific CD8+ T cells , 2023, Scandinavian Journal of Immunology.
[5] V. Furer,et al. Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study , 2023, Vaccines.
[6] O. Duperrex,et al. Incidence of Chronic Spontaneous Urticaria Following Receipt of the COVID-19 Vaccine Booster in Switzerland , 2023, JAMA network open.
[7] Y. Ohira,et al. Cholinergic Urticaria After COVID-19 Infection , 2022, The American Journal of Medicine.
[8] P. Tuchinda,et al. Disease activity of patients with chronic urticaria receiving COVID-19 vaccines. , 2022, Asian Pacific journal of allergy and immunology.
[9] Silada Kanokrungsee,et al. Can mRNA COVID‐19 vaccines induce flares of chronic urticaria? , 2022, Journal of Cosmetic Dermatology.
[10] F. Mori,et al. Relapse or worsening of chronic spontaneous urticaria during SARS-CoV-2 infection and vaccination in children: A telemedicine follow-up. , 2022, Allergologia et immunopathologia.
[11] G. Fabbrocini,et al. Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience , 2022, Dermatologic therapy.
[12] M. Maurer,et al. Urticaria , 2022, Nature Reviews Disease Primers.
[13] P. Gisondi,et al. Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis , 2022, Vaccines.
[14] C. Ribi,et al. Clinical and immunological data from chronic urticaria onset after mRNA SARS‐CoV‐2 vaccines , 2022, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[15] S. Lipner,et al. Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database , 2022, American Journal of Clinical Dermatology.
[16] E. Freeman,et al. Urticaria and/or angioedema secondary to mRNA COVID‐19 vaccines: Updates from a United States case registry , 2022, Allergy.
[17] P. Ochieng,et al. COVID-19 Vaccine Booster-Induced Dermatographism , 2022, Cureus.
[18] Ö. Yılmaz,et al. Angioedema Related to Infectious Mononucleosis , 2022, Trends in Pediatrics.
[19] Brenda Chiang,et al. Coronavirus disease-19 infection and angioedema in African Americans: A case series , 2022, Otolaryngology Case Reports.
[20] M. Mirsaeidi,et al. SARS-CoV-2 cell entry beyond the ACE2 receptor , 2022, Molecular Biology Reports.
[21] J. Phannajit,et al. Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID‐19 vaccination: A systematic review and meta‐analysis , 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.
[22] M. Maurer,et al. Autoimmune chronic spontaneous urticaria. , 2022, The Journal of allergy and clinical immunology.
[23] E. Freeman,et al. Chronic spontaneous urticaria after COVID-19 primary vaccine series and boosters , 2022, JAAD Case Reports.
[24] L. de Montjoye,et al. Chronic spontaneous urticaria following COVID-19 vaccination , 2022, JAAD Case Reports.
[25] R. M. McLarney,et al. Yellow Urticaria. , 2022, JAMA dermatology.
[26] G. Pellacani,et al. Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study , 2022, Journal of clinical medicine.
[27] Adrian Y. S. Lee,et al. Chronic spontaneous urticaria following ChAdOx1-S COVID-19 vaccination , 2022, Allergo Journal International.
[28] D. Brǎnișteanu,et al. Mucocutaneous lesions associated with SARS-CoV-2 infection (Review) , 2022, Experimental and therapeutic medicine.
[29] C. Janson,et al. Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper , 2022, Allergy.
[30] Xiaoqing Fu,et al. Urticaria and/or angioedema events secondary to mRNA COVID-19 vaccinations - Updates from a national case registry , 2022, Journal of Allergy and Clinical Immunology.
[31] F. Sodeifian,et al. Cutaneous manifestation of COVID-19: What have we learned an year into the pandemic? , 2022, Actas Dermo-Sifiliográficas.
[32] G. Aytekin,et al. The course of COVID-19 in patients with chronic spontaneous urticaria receiving omalizumab treatment , 2022, Revue Française d'Allergologie.
[33] L. Rello,et al. Experience with Cutaneous Manifestations in COVID-19 Patients during the Pandemic , 2022, Journal of clinical medicine.
[34] A. Linē,et al. Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients , 2022, Journal of translational medicine.
[35] S. Chiarella,et al. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination. , 2022, Allergy and asthma proceedings.
[36] I. Green,et al. Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2. , 2022, Allergy and asthma proceedings.
[37] M. Abbaslou,et al. Chronic Spontaneous Urticaria Triggered by the AstraZeneca/Oxford COVID-19 Vaccine with Achieved Remission: A Case Report , 2022, Allergy & rhinology.
[38] N. Garrett,et al. Allergic reactions to the Ad26.COV2.S Vaccine in South Africa , 2021, Journal of Allergy and Clinical Immunology: Global.
[39] J. Klaewsongkram,et al. Acute urticaria alone after CoronaVac COVID‐19 vaccination should not be a contraindication for revaccination , 2021, Clinical and experimental dermatology.
[40] Duygu Gulseren,et al. The effect of COVID‐19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: A cross‐sectional, comparative study , 2021, Journal of cosmetic dermatology.
[41] N. Conlon,et al. Rapid transition to home omalizumab treatment for chronic spontaneous urticaria during the COVID-19 pandemic: A patient perspective , 2021, World Allergy Organization Journal.
[42] T. Zuberbier,et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria , 2021, Allergy.
[43] E. Wherry,et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19 , 2021, Nature Communications.
[44] H. Miot,et al. COVID‐19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.
[45] D. Rosmarin,et al. Comparison of constitutional and dermatologic side effects between COVID-19 and non–COVID-19 vaccines: Review of a publicly available database of vaccine side effects , 2021, Journal of the American Academy of Dermatology.
[46] George Thomas,et al. Chronic Spontaneous Urticaria After COVID-19 Vaccine , 2021, Cureus.
[47] I. Muntean,et al. COVID-19 Disease Leading to Chronic Spontaneous Urticaria Exacerbation: A Romanian Retrospective Study , 2021, Healthcare.
[48] N. Rezaei,et al. [Artículo traducido] Manifestaciones cutáneas de la COVID-19: ¿Qué hemos aprendido tras un año de pandemia? , 2021, Actas Dermo-Sifiliográficas.
[49] V. Khavinson,et al. Homology between SARS CoV-2 and human proteins , 2021, Scientific Reports.
[50] M. Rudenko. The Role of Infection and Autoimmunity in Urticaria and Angioedema as a Common Entity , 2021, EMJ Allergy & Immunology.
[51] I. Zalaudek,et al. Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes , 2021, Clinical, cosmetic and investigational dermatology.
[52] A. Ołdakowska,et al. Urticaria multiforme in a child with SARS-CoV-2 infection , 2021, Dermatology reports.
[53] M. Llamas-Velasco,et al. Cutaneous reactions after SARS‐CoV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases , 2021, The British journal of dermatology.
[54] Ş. Beyaz,et al. Psychological burden of COVID-19 on mild and moderate chronic spontaneous urticarial. , 2021, Allergy and asthma proceedings.
[55] Paige G. Wickner,et al. Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines. , 2021, JAMA dermatology.
[56] Paige G. Wickner,et al. Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination , 2021, The Journal of Allergy and Clinical Immunology: In Practice.
[57] J. Quaresma,et al. Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals☆☆☆ , 2021, Anais brasileiros de dermatologia.
[58] N. Tsankov,et al. Cutaneous adverse effects of the available COVID-19 vaccines , 2021, Clinics in Dermatology.
[59] Joon Seo Lim,et al. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea , 2021, Journal of Korean medical science.
[60] L. Naldi,et al. Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review , 2021, Dermatology and Therapy.
[61] M. Maurer,et al. Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review , 2021, Allergy.
[62] J. Lipoff,et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases , 2021, Journal of the American Academy of Dermatology.
[63] Ryan D. Morin,et al. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody , 2021, Frontiers in Immunology.
[64] F. Rodieux,et al. Viral Infections and Cutaneous Drug-Related Eruptions , 2021, Frontiers in Pharmacology.
[65] V. Koumaki,et al. Childhood Acute Urticaria and Seasonal Patterns Presenting in the Emergency Department of a Teaching Hospital in London, United Kingdom , 2021, Pediatric emergency care.
[66] A. Vojdani,et al. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases , 2021, Frontiers in Immunology.
[67] G. Fabbrocini,et al. The clinical spectrum of COVID-19–associated cutaneous manifestations: An Italian multicenter study of 200 adult patients , 2021, Journal of the American Academy of Dermatology.
[68] J. Lipoff,et al. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration , 2021, The Lancet Infectious Diseases.
[69] Fernanda Bellodi Schmidt,et al. Acute urticaria preceding other COVID‐19–associated manifestations—A case report , 2021, Pediatric dermatology.
[70] J. Vrieze. Suspicions grow that nanoparticles in Pfizer’s COVID-19 vaccine trigger rare allergic reactions , 2020, Science.
[71] A. Lavezzi,et al. Neuropathological explanation of minimal COVID-19 infection rate in newborns, infants and children – a mystery so far. New insight into the role of Substance P , 2020, Journal of the Neurological Sciences.
[72] Y. Tam,et al. Skin manifestations of COVID-19: A worldwide review , 2020, JAAD International.
[73] T. Zuberbier,et al. The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria , 2020, Allergy.
[74] T. Theoharides. Potential association of mast cells with coronavirus disease 2019 , 2020, Annals of Allergy, Asthma & Immunology.
[75] S. Aronin,et al. COVID-19 (SARS-CoV-2) infection presenting as acute urticaria , 2020, Clinics in Dermatology.
[76] S. Algaadi. Urticaria and COVID‐19: A review , 2020, Dermatologic therapy.
[77] M. Idzko,et al. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic , 2020, Allergologie select.
[78] C. Pagliari,et al. What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID‐19 or asymptomatic infections due to SARS‐CoV‐2? , 2020, Dermatologic therapy.
[79] R. Thangavel,et al. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation , 2020, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[80] F. Marceau,et al. Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants , 2020, Frontiers in Medicine.
[81] V. Bogin,et al. Clinical characteristics of dermatologic manifestations of COVID‐19 infection: case series of 15 patients, review of literature, and proposed etiological classification , 2020, International journal of dermatology.
[82] A. S. St. John,et al. Protective and pathogenic roles for mast cells during viral infections , 2020, Current Opinion in Immunology.
[83] M. Triggiani,et al. Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions , 2020, Journal of Allergy and Clinical Immunology.
[84] M. Fernández-Guarino,et al. Urticarial vasculitis in COVID‐19 infection: a vasculopathy‐related symptom? , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.
[85] J. Saurat,et al. Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature , 2020, Dermatopathology.
[86] J. Lipoff,et al. The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries , 2020, Journal of the American Academy of Dermatology.
[87] A. Vojdani,et al. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases , 2020, Clinical Immunology.
[88] A. Friedman,et al. COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2? , 2020, Journal of drugs in dermatology : JDD.
[89] C. A. González-Cruz,et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases , 2020, The British journal of dermatology.
[90] S. Saussez,et al. Acute urticaria with pyrexia as the first manifestations of a COVID‐19 infection , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.
[91] David Berlin,et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases , 2020, Translational Research.
[92] É. Estève,et al. Urticarial eruption in COVID‐19 infection , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.
[93] C. Akdis,et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.
[94] A. Dudeck,et al. Mast cells initiate the vascular response to contact allergens by sensing cell stress. , 2020, The Journal of allergy and clinical immunology.
[95] L. Bielory,et al. Mast Cell Biology at Molecular Level: a Comprehensive Review , 2019, Clinical Reviews in Allergy & Immunology.
[96] M. Maurer,et al. A case of dengue fever presenting with acute urticaria. , 2019, Asian Pacific journal of allergy and immunology.
[97] A. Didierlaurent,et al. The how’s and what’s of vaccine reactogenicity , 2019, npj Vaccines.
[98] J. Marshall,et al. Mast Cell Responses to Viruses and Pathogen Products , 2019, International journal of molecular sciences.
[99] M. Maurer,et al. Treatment of urticarial vasculitis: A systematic review , 2019, The Journal of allergy and clinical immunology.
[100] Jing-Yang Huang,et al. Patients with urticaria are at a higher risk of anaphylaxis: A nationwide population‐based retrospective cohort study in Taiwan , 2018, The Journal of dermatology.
[101] M. Maurer,et al. Comorbidity of viral hepatitis and chronic spontaneous urticaria: A systematic review , 2018, Allergy.
[102] Y. Shoenfeld,et al. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction , 2018, Cellular & Molecular Immunology.
[103] F. Redegeld,et al. Non‐IgE mediated mast cell activation , 2018, Immunological reviews.
[104] D. Metcalfe,et al. Mast cells signal their importance in health and disease. , 2018, The Journal of allergy and clinical immunology.
[105] W. Busse,et al. Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab , 2017, The Journal of allergy and clinical immunology.
[106] E. Iemoli,et al. Successful Omalizumab treatment in HIV positive patient with chronic spontaneous urticaria: a case report. , 2017, European annals of allergy and clinical immunology.
[107] Shakeel Ahmed,et al. Hepatitis C seropositivity in patients with acute and chronic urticaria , 2016 .
[108] J. Mishal,et al. The clinical and laboratory characteristics of acute spontaneous urticaria and its progression to chronic spontaneous urticaria. , 2016, Allergy and asthma proceedings.
[109] J. Bousquet,et al. Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence , 2016, Allergy.
[110] D. Metcalfe,et al. IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3. , 2016, The Journal of allergy and clinical immunology.
[111] M. Levi,et al. Epidemiology of chronic spontaneous urticaria: results from a nationwide, population‐based study in Italy , 2016, The British journal of dermatology.
[112] D. Dreyfus,et al. Serological evidence that activation of ubiquitous human herpesvirus‐6 (HHV‐6) plays a role in chronic idiopathic/spontaneous urticaria (CIU) , 2016, Clinical and experimental immunology.
[113] S. Bulfone-Paus,et al. Mast Cells as Regulators of T Cell Responses , 2015, Front. Immunol..
[114] A. Graham,et al. Mast Cells and Influenza A Virus: Association with Allergic Responses and Beyond , 2015, Front. Immunol..
[115] M. Becker,et al. Mast cells: innate attractors recruiting protective CD8 T cells to sites of cytomegalovirus infection , 2015, Medical Microbiology and Immunology.
[116] T. Xiao,et al. Acute Urticaria Caused By Infection In 72 Chinese Patients , 2014 .
[117] S. Adler,et al. Herpesvirus-Associated Acute Urticaria: An Age Matched Case-Control Study , 2013, PloS one.
[118] B. Wedi,et al. Management of childhood urticaria: current knowledge and practical recommendations. , 2013, Acta dermato-venereologica.
[119] G. Karakaya,et al. The general characteristics of acute urticaria attacks and the factors predictive of progression to chronic urticaria. , 2013, Allergologia et immunopathologia.
[120] D. Kevat,et al. Chronic urticaria following acute hepatitis A , 2012, BMJ Case Reports.
[121] D. Dreyfus. Autoimmune disease: A role for new anti-viral therapies? , 2011, Autoimmunity reviews.
[122] Rob van Aalsburg,et al. Urticaria and Periorbital Edema as Prodromal Presenting Signs of Acute Hepatitis B Infection , 2011 .
[123] N. Papadopoulos,et al. Childhood acute urticaria in northern and southern Europe shows a similar epidemiological pattern and significant meteorological influences , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[124] M. Masi,et al. Allergy is not the main trigger of urticaria in children referred to the emergency room , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.
[125] K. Godse,et al. Chronic urticaria associated with recurrent genital herpes simplex infection and success of antiviral therapy--a report of two cases. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[126] R. Platt,et al. Outpatient urticaria diagnosis codes have limited predictive value for same-day influenza vaccine adverse event detection. , 2010, Journal of clinical epidemiology.
[127] S. Arias-Santiago,et al. [Cold urticaria associated with Epstein barr virus mononucleosis]. , 2009, Actas dermo-sifiliograficas.
[128] S. Arias-Santiago,et al. Urticaria a frigore asociada a mononucleosis por virus de Epstein-Barr , 2009 .
[129] P. Altmeyer,et al. Urticaria associated with Norovirus infection: Report of two cases , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[130] Yan-Ren Lin,et al. First attack of acute urticaria in pediatric emergency department. , 2008, Pediatrics and neonatology.
[131] S. Jiamton,et al. Acute urticaria: etiologies, clinical course and quality of life. , 2008, Asian Pacific journal of allergy and immunology.
[132] D. Lipsker,et al. Acute urticaria and dry cough with interstitial pneumonia: a clue for the diagnosis of primary parvovirus B19 infection , 2006, Clinical and experimental dermatology.
[133] B. Cribier. Urticaria and hepatitis , 2006, Clinical reviews in allergy & immunology.
[134] B. Wedi,et al. Chronic urticaria and infections , 2004, Current opinion in allergy and clinical immunology.
[135] C. Grattan,et al. Drug-induced urticaria , 2004, Expert opinion on drug safety.
[136] C. Saçkesen,et al. The Etiology of Different Forms of Urticaria in Childhood , 2004, Pediatric dermatology.
[137] S. Nikkari,et al. Presence of parvovirus B19 DNA in chronic urticaric and healthy human skin. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[138] N. Naing,et al. Cutaneous manifestations in HIV positive patients. , 2001, The Southeast Asian journal of tropical medicine and public health.
[139] J. Pijoan,et al. [Round Table: Urticaria in relation to infections]. , 1999, Allergologia et immunopathologia.
[140] A. Taïeb,et al. Acute urticaria in infancy and early childhood: a prospective study. , 1998, Archives of dermatology.
[141] R. Yu,et al. Cold urticaria, raised IgE and HIV infection. , 1995, Journal of the Royal Society of Medicine.
[142] R. Sutter,et al. Adverse reactions to tetanus toxoid. , 1994, JAMA.
[143] T. Aoki,et al. Acute Urticaria: History and Natural Course of 50 Cases , 1994, The Journal of dermatology.
[144] P. Puska,et al. Effect of PUVA on immunologic and virologic findings in HIV-infected patients. , 1991, Journal of the American Academy of Dermatology.
[145] A. Taïeb,et al. Urticaria in Infants: A Study of Forty Patients , 1990, Pediatric dermatology.
[146] R. Sorensen,et al. URTICARIA FOLLOWING ADMINISTRATION OF DIPHTHERIA-TETANUS TOXOIDS-PERTUSSIS VACCINE , 1987 .
[147] C. LópezSerrano,et al. Cold urticaria associated with serologic markers of hepatitis B and cryoglobulinemia , 1987 .
[148] J. Schirm,et al. Cold urticaria and virus infections: a clinical and serological study in 39 patients , 1986, The British journal of dermatology.
[149] H. Hurley,et al. Urticaria as a sign of viral hepatitis. , 1972, Archives of dermatology.
[150] R. Champion,et al. URTICARIA AND ANGIO‐OEDEMA , 1969, The British journal of dermatology.
[151] Sheldon Jm,et al. The vexing urticaria problem: present concepts of etiology and management. , 1954, The Journal of allergy.
[152] Ö. Özdemir. Parainfluenza Type 3 Virus as an Etiological Cause of Acute Urticaria In a Patient , 2020 .
[153] Journal Ijar,et al. THE EFFECT OF TAURINE ON METHOTREXATE INDUCED HEPATORENAL TOXICITY IN RATS. , 2018 .
[154] S. Gangemi,et al. Association between urticaria and virus infections: A systematic review. , 2016, Allergy and asthma proceedings.
[155] Ruth A Sabroe. Acute urticaria. , 2014, Immunology and allergy clinics of North America.
[156] H. Yingying,et al. The relationship between chronic urticaria and hepatitis B virus infection. , 2009 .
[157] B. Wedi,et al. Urticaria and infections , 2009 .
[158] T. Uyeki,et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. , 2008, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[159] S. Miyake,et al. Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases. , 2007, Allergology international : official journal of the Japanese Society of Allergology.
[160] F. Granata,et al. Role of superallergens in allergic disorders. , 2007, Chemical immunology and allergy.
[161] M. T. Caballero,et al. Epidemiology of urticaria in Spain. , 2004, Journal of investigational allergology & clinical immunology.
[162] C. Bridges,et al. Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2004 .
[163] Lead Visual Information Specialist , 2001 .
[164] U. Bauer,et al. [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.
[165] D. Metcalfe,et al. Mast cells. , 1997, Physiological reviews.
[166] L. Scully,et al. Urticaria and acute hepatitis A virus infection. , 1993, The American journal of gastroenterology.
[167] P. Barranco Sanz,et al. [Cold urticaria associated with serologic markers of hepatitis B and cryoglobulinemia]. , 1987, Allergologia et Immunopathologia.